The closing of the sale of a controlling stake in Opella to CD&R is anticipated in Q2
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNY:
- Innate Pharma announces EUR 15M capital increase from Sanofi
- Sanofi’s Strong Financial Performance and Promising R&D Pipeline Justify Buy Rating
- Innate Pharma regains rights to Anket, announces potential Sanofi investment
- Sanofi’s Dupixent Gains FDA Approval for Chronic Spontaneous Urticaria
- Trump looking at cutting drug prices to international levels, Reuters says